51 – 60 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study
(
- Contribution to journal › Article
-
Mark
Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study
(
- Contribution to journal › Article
-
Mark
Diagnostic work-up of contralateral breast cancers has not improved over calendar period
(
- Contribution to journal › Article
- 2009
-
Mark
No evidence that GATA3 rs570613 SNP modifies breast cancer risk
(
- Contribution to journal › Article
-
Mark
Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer
(
- Contribution to journal › Article
- 2008
-
Mark
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
(
- Contribution to journal › Article
-
Mark
HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
(
- Contribution to journal › Article
-
Mark
Exploring the two-gene ratio in breast cancer-independent roles for HOXB13 and IL17BR in prediction of clinical outcome
(
- Contribution to journal › Article
- 2007
-
Mark
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
(
- Contribution to journal › Article
- 2005
-
Mark
Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression.
(
- Contribution to journal › Article